Basic Materials / Specialty ChemicalsBSE
$237.50
-6.50 (-2.66%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-77.3M · quality 65.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
62/100
B
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$3.6B
P/E
23.1x
↑EV/EBITDA
9.6x
↓ROE
13.6%
↑Gross Margin
13.0%
↓Debt/Equity
0.25
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+15.1%
FCF CAGR
—
FCF margin
-5.7%
FCF / Net income
-0.94x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $2.15B · net income $131.2M · FCF $-123.4M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $2.15B | $2.15B | $1.88B | $2.28B | $1.41B |
| Net Income | $131.2M | $131.2M | $51.1M | $29.4M | $27.4M |
| EBITDA | $246.1M | $246.1M | $122.1M | $89.4M | $66.9M |
| EPS | 13.42 | 13.42 | 3.96 | 2.27 | 2.12 |
| Gross Margin | 13.0% | 13.0% | 8.2% | 9.1% | 10.9% |
| Operating Margin | 9.7% | 9.7% | 5.4% | 2.8% | 3.2% |
| Net Margin | 6.1% | 6.1% | 2.7% | 1.3% | 1.9% |
| Balance Sheet | |||||
| Debt/Equity | 0.25 | 0.25 | 1.56 | 3.02 | 2.29 |
| Current Ratio | 3.57 | 3.57 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-123.4M | $-123.4M | $-33.7M | $-77.3M | $-58.8M |
| Returns | |||||
| ROE | 13.6% | 13.6% | 21.5% | 20.5% | 26.2% |
| Valuation | |||||
| P/E | 23.06 | 23.06 | — | — | — |
| EV/EBITDA | 9.60 | 9.60 | — | — | — |
| P/B | 2.40 | 2.40 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 14.5% | 14.5% | -17.7% | 61.7% | — |
| EPS Growth | 239.1% | 239.1% | 74.2% | 7.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
16.2%
EPS terminal req.
$21.07
Spread vs growth
222.9%
5Y implied EPS CAGR
13.7%
EPS terminal req.
$25.50
Spread vs growth
225.4%
10Y implied EPS CAGR
11.8%
EPS terminal req.
$41.07
Spread vs growth
227.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+7.2%
Start / end P/E
56.0x → 17.7x
EPS bridge
3.96 → 13.42
Residual
-163.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.